semaglutide covered by medi-cal Under a regulation proposed last week the Centers for Medicare & Medicaid Services (CMS), Medicare and Medicaid recipients with obesity could gain access to coverage for costly GLP-1 receptor agonists like Semaglutide GLP-1 Medical Weight Loss

doi:10.1345/aph.1K531

Islet interleukin-1beta immunoreactivity is an early feature of cystic fibrosis that may contribute to beta-cell failure

52 In addition, most cancer cells are extremely vulnerable to glucose withdrawal, 53, 54, 55, 56, 57, 58, 59 a feature they owe to metabolic reprogramming, leading to constitutively active proliferation pathways and glucose addiction

While these drugs offer significant benefits for metabolic health, their impact on cancer risk requires careful consideration

The two are used together: ipamorelin prompts a growth-hormone pulse and CJC-1295 extends it, making the combination more potent than either compound alone

Commitment: Most patients in 2026 understand that weight regain is common if the medication is stopped without a strict maintenance plan